Additionally, there was a reduction in both programmed death ligand 1 (PD-L1) and PD-L2 MFIs in PMN-MDSCs from BRQ-treated tumor-bearing mice (Figure 6C), supporting the notion that these PMN-MDSCs are less suppressive relative to the vehicle-treated controls. This evidence concerns the gene CD274 and neoplasm.